Zobrazeno 1 - 9
of 9
pro vyhledávání: '"R W, Quenzer"'
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 28(6)
Diabetic patients suspected of having osteomyelitis secondary to foot ulcers underwent scintigraphic imaging with Sulesomab, an anti-granulocyte antibody Fab' fragment labeled with technetium-99m. Among 122 patients who had osteomyelitis confirmed or
Publikováno v:
The American journal of managed care. 3(7)
An interactive pharmacoeconomic model was designed to evaluate the effects of clinical response and adverse drug events on the comparative cost and cost-effectiveness of a relatively new antibiotic, clarithromycin, compared with those of six other an
Autor:
R C, Bone, R A, Balk, A M, Fein, T M, Perl, R P, Wenzel, H D, Reines, R W, Quenzer, T J, Iberti, N, Macintyre, R M, Schein
Publikováno v:
Critical care medicine. 23(6)
To evaluate the safety and efficacy of E5, a murine, monoclonal antibody directed against endotoxin, in the treatment of patients with Gram-negative sepsis.A multicenter, randomized, double-blind, placebo-controlled trial.Fifty-three hospitals across
Autor:
J L, LeFrock, A M, Ristuccia, P A, Ristuccia, R W, Quenzer, P G, Haggerty, J E, Allen, L A, Lettau, R, Schwartz, D, Appleby
Publikováno v:
The European journal of surgery. Supplement. : = Acta chirurgica. Supplement. (567)
Teicoplanin is a new glycopeptide antibiotic with activity against Gram-positive bacteria, including methicillin-resistant organisms. Teicoplanin is administered once daily, either intravenously or intramuscularly. Teicoplanin was given once daily, i
Autor:
A Plauche, C Stidley, T Anderson, A Mangalik, R W Quenzer, J J Rinehart, W Kohler, James A. Neidhart
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 8(10)
Forty-two patients with advanced malignancy judged unlikely to respond to standard treatment received high-dose combination chemotherapy with cyclophosphamide, etoposide, and cisplatin in a phase I trial. Twenty-two of these patients who had at least
Publikováno v:
Nuclear Medicine Communications. 17:285
Autor:
B A, Mann, R W, Quenzer
Publikováno v:
The Western journal of medicine. 147(2)
Publikováno v:
JAMA. 238(17)
Autor:
R. W. Quenzer
Publikováno v:
JAMA: The Journal of the American Medical Association. 238:1845-1845